Fluticasone Propionate-salmeterol Combination Adherence in Patients With Chronic Obstructive Pulmonary Disease (COPD)

NCT01381471 · clinicaltrials.gov ↗

COMPLETED

Status

11060

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: fluticasone propionate/salmeterol xinafoate combination

Sponsor

GlaxoSmithKline